Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Synthetic double-stranded siRNA oligonucleotide directed against hydroxyacid oxidase 1 mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues

EU orphan designation number: EU/3/16/1637   
Active ingredient: Synthetic double-stranded siRNA oligonucleotide directed against hydroxyacid oxidase 1 mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues
Indication: Treatment of primary hyperoxaluria
Sponsor: Alnylam UK Limited
5 New Street Square, London EC4A 3TW, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/03/2016 Orphan designation EMA/OD/195/15 (2016)1875 of 21/03/2016